WASHINGTON, DC—Administering tranexamic acid during noncardiac surgery provides a clear reduction in bleeding, with a low likelihood of harm in terms of vascular complications, the POISE-3 trial shows ...

The use of an older medication at the time of surgery can reduce the need for red blood cell transfusions, according to a ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Tranexamic acid administered intravenously before and after noncardiac surgery lowered the risk for ...

A dose of tranexamic acid to start and end noncardiac surgery reduced important bleeding events, the POISE-3 trial showed, albeit with a question mark hanging over cardiovascular risk. The ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Tranexamic acid ...

Local injection of tranexamic acid (TXA) effectively reduced the risk for clinically significant bleeding following Mohs micrographic surgery (MMS), results from a single-center cohort study showed.

When hospitals were randomly assigned to treat patients undergoing higher-risk non-cardiac surgery with tranexamic acid (TXA) ...

Tranexamic acid lowers the need for transfusions for patients undergoing non-cardiac surgeries and does not increase the risk for venous thromboembolism, according to data presented at ASH Annual ...

Prophylactic use of tranexamic acid at the time of cesarean delivery has been shown to decrease the calculated blood loss, but the effect on the need for blood transfusions is unclear. We randomly ...